Skip to main content Accessibility help
×
Home

Motor timing variability increases in preclinical Huntington's disease patients as estimated onset of motor symptoms approaches

  • SEAN C. HINTON (a1), JANE S. PAULSEN (a2), RAYMOND G. HOFFMANN (a3), NORMAN C. REYNOLDS (a1), JANICE L. ZIMBELMAN (a1) and STEPHEN M. RAO (a1)...

Abstract

Huntington's disease (HD) is a neurodegenerative disorder diagnosed clinically with the development of choreiform movements. However, neuropsychological studies have demonstrated cognitive and psychiatric changes during the preclinical phase (pre-HD) prior to formal diagnosis. Previous studies have demonstrated the sensitivity of time reproduction tasks to basal ganglia pathology, as seen in clinical HD and Parkinson's disease. In this study, 29 pre-HD participants, ranging from 3 to 39 years from estimated onset (YEO) of HD based on genetic testing and chronological age, were administered the paced finger-tapping task using target intervals of 600 and 1200 ms. Mean inter-response interval, a measure of timing accuracy, did not systematically deviate from the target interval as a function of YEO. In contrast, timing variability increased curvilinearly as a function of YEO, but not with chronological age alone. Motor timing variability, but not accuracy, may serve as a marker to define the earliest behavioral changes in HD. The present study is among the first to examine the relationship between behavioral measures and YEO in pre-HD. (JINS, 2007, 13, 539–543.)

Copyright

Corresponding author

Correspondence and reprint requests to: Stephen M. Rao, Ph.D., Medical College of Wisconsin, 8701 Watertown Plank Road, MEB 4530, Milwaukee, WI 53226, USA. E-mail: srao@mcw.edu

References

Hide All

REFERENCES

Aylward, E.H., Codori, A.M., Rosenblatt, A., Sherr, M., Brandt, J., Stine, O.C., Barta, P.E., Pearlson, G.D., & Ross, C.A. (2000). Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Movement Disorders, 15, 552560.
Aylward, E.H., Reiss, A.L., Reader, M.J., Singer, H.S., Brown, J.E., & Denckla, M.B. (1996). Basal ganglia volumes in children with attention-deficit hyperactivity disorder. Journal of Child Neurology, 11, 112115.
Aylward, E.H., Sparks, B.F., Field, K.M., Yallapragada, V., Shpritz, B.D., Rosenblatt, A., Brandt, J., Gourley, L.M., Liang, K., Zhou, H., Margolis, R.L., & Ross, C.A. (2004). Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology, 63, 6672.
Campodonico, J.R., Aylward, E., Codori, A.M., Young, C., Krafft, L., Magdalinski, M., Ranen, N., Slavney, P.R., & Brandt, J. (1998). When does Huntington's disease begin? Journal of the International Neuropsychological Society, 4, 467473.
Elsinger, C.L., Rao, S.M., Zimbelman, J.L., Reynolds, N.C., Blindauer, K.A., & Hoffmann, R.G. (2003). Neural basis for impaired time reproduction in Parkinson's disease: An fMRI study. Journal of the International Neuropsychological Society, 9, 10881098.
Harrington, D.L. & Haaland, K.Y. (1999). Neural underpinnings of temporal processing: A review of focal lesion, pharmacological, and functional imaging research. Reviews in the Neurosciences, 10, 91116.
Harrington, D.L., Haaland, K.Y., & Hermanowicz, N. (1998). Temporal processing in the basal ganglia. Neuropsychology, 12, 312.
Hersch, S.M. & Rosas, H.D. (2001). Neuroprotective therapy for Huntington's disease: New prospects and challenges. Expert Review of Neurotherapeutics, 1, 111118.
Huntington Study Group (1996). Unified Huntington's Disease Rating Scale: Reliability and consistency. Movement Disorders, 11, 136142.
Langbehn, D.R., Brinkman, R.R., Falush, D., Paulsen, J.S., Hayden, M.R., & International Huntington's Disease Collaborative Group. (2004). A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics, 65, 267277.
Paulsen, J.S., Hayden, M., Stout, J.C., Langbehn, D.R., Aylward, E., Ross, C.A., Guttman, M., Nance, M., Kieburtz, K., Oakes, D., Shoulson, I., Kayson, E., Johnson, S., Penziner, E., & the Predict-HD Investigators of the Huntington Study Group (2006). Preparing for preventive clinical trials: The Predict-HD study. Archives of Neurology, 63, 883890.
Paulsen, J.S., Zhao, H., Stout, J.C., Brinkman, R.R., Guttman, M., Ross, C.A., Como, P., Manning, C., Hayden, M.R., & Shoulson, I. (2001). Clinical markers of early disease in persons near onset of Huntington's disease. Neurology, 57, 658662.
Paulsen, J.S., Zimbelman, J.L., Hinton, S.C., Langbehn, D.R., Leveroni, C.L., Benjamin, M.L., Reynolds, N.C., & Rao, S.M. (2004). fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. American Journal of Neuroradiology, 25, 17151721.
Rao, S.M., Harrington, D.L., Haaland, K.Y., Bobholz, J.A., Cox, R.W., & Binder, J.R. (1997). Distributed neural systems underlying the timing of movements. Journal of Neuroscience, 17, 55285535.
Rao, S.M., Mayer, A.R., & Harrington, D.L. (2001). The evolution of brain activation during temporal processing. Nature Neuroscience, 4, 317323.
Woodruff-Pak, D.S. & Papka, M. (1996). Huntington's disease and eyeblink classical conditioning: Normal learning but abnormal timing. Journal of the International Neuropsychological Society, 2, 323334.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed